Patent US4731394A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4731394A Expired / Lapsed US ⏱️ 0.0 years remaining

Inorganic-organic compound substances for biomedical purposes

Assignee: FRIEDRICH-SCHILLER-UNIVERSITAET JENA A CORP OF GERMANY
•
Filing: 1986-06-12
•
Granted: 1988-03-15
•
Expires: 2006-06-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention relates to inorganic-organic compound substances useful for biomedical purposes. The object of the invention is to develop inorganic-organic compound materials which overcome the disadvantages of the state of art, wherein inorganic-organic compound substances for biomedical purposes possess to a large extent specifically adjustable characteristics. Inorganic initial substances form a new solid chemical compound with organic initial substances. The inorganic initial component consists of a biocompatible silicate glass and/or a silicate glass ceramic of the system SiO2-Al2O3-MgO-Na2O/K2O-F-, and/or a bioactive phosphate silicate glass and/or a phosphate silicate glass ceramic of the system SiO2-Al2O3-MgO-Na2O/K2O-CaO-P2O5F- and/or of the system SiO2-MgO-K2O-F--CaO-P2O5, and/or a bioactive phosphate glass and/or a phosphate glass ceramic of the system P2O5-Al2O3-CaO-Na2O/K2O, and/or a sintred ceramic based upon tricalcium phosphate and/or apatite. The organic initial component consists of a biocompatible, monomer-free, epoxidized polymeric hydrocarbon consisting only of the elements C, H, O having an average molecular weight &upbar& M of 2,000 to 6,000 and an epoxy equivalence EEW of 50 to 500 g. The inorganic initial component is modified by phosphoric acid.

Inventors

  • 👤 Werner Vogel
  • 👤 Guenther Heublein
  • 👤 Wolfram Hoeland
  • 👤 Manfred Boese
  • 👤 Karin Naumann
  • 👤 Gunter Carl
  • 👤 Juergen Vogel
  • 👤 Peter Wange
  • 👤 Jens Gummel
  • 👤 Peter Zinner
  • 👤 Eggert Beleites
  • 👤 Thomas Schubert

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 22:39
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/40; A61L27/44; A61L27/46; A61K; A61K6/00; A61K6/60; A61K6/65; A61K6/66; A61K6/69; A61K6/70; A61K6/78; A61K6/80; A61K6/802; A61K6/807; A61K6/813; A61K6/816; A61K6/831; A61K6/833

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 330 words
Inorganic-organic compound substances useful for biomedical purposes, comprising 30 to 80 weight-% of an inorganic initial material chemically bonded with 20 to 70 weight-% of an organic initial material, wherein the inorganic initial material is selected from the group consisting of a biocompatable silicate glass, silicate glass ceramic or mixtures thereof having a composition by weight % of ______________________________________ SiO.sub.2 = 34-60 Al.sub.2 O.sub.3 = 21-36 MgO = 8-17 R.sub.2 O = 5-12 F.sup.- = 1-7 ______________________________________ wherein R 2 O represents the sum of 0-8 weight-% Na 2 O and 0-6 weight-% K 2 O, a bioactive phosphosilicate glass, a phosphosilicate glass ceramic (A) or mixtures thereof having a composition by weight % of ______________________________________ SiO.sub.2 = 19-52 Al.sub.2 O.sub.3 = 12-23 MgO 5-15 R.sub.2 O = 3-10 CaO = 9-30 P.sub.2 O.sub.5 4-24 F.sup.- 0.5-7 ______________________________________ wherein R 2 O represents the sum of 0-8 weight-% Na 2 O and 0-8 weight-% K 2 O, a bioactive phosphosilicate glass, a phosphosilicate glass ceramic (B) or mixtures thereof having a composition by weight % of ______________________________________ SiO.sub.2 = 18-63 MgO = 10-35 K.sub.2 O = 3-10 F.sup.- = 4-9 CaO = 1-30 P.sub.2 O.sub.5 = 1-30 ______________________________________ a bioactive phosphate glass, a phosphate glass ceramic or mixtures thereof having a composition by weight % of ______________________________________ P.sub.2 O.sub.5 = 43-58 Al.sub.2 O.sub.3 = 3-21 CaO = 8-26 R.sub.2 O = 10-25 ______________________________________ wherein R 2 O can contain up to 25 weight-% Na 2 O and up to 18 weight-% K 2 O, a sintered ceramic comprising tricalcium phosphate apatite or mixtures thereof and mixtures thereof, and the organic initial material comprises a biocompatible, monomer-free, epoxidized polymeric hydrocarbon composed only of the elements C, H, O having an average molecular weight Mn of 2,000 to 6,000 and an epoxy equivalence EEW of 50 to 500 g, wherein the inorganic initial material has been pretreated with phosphoric acid to facilitate said chemical bonding between the organic and inorganic initial materials.
Claim 2
Dependent Claim 330 words
Inorganic-organic compound substances useful for biomedical purposes, comprising 30 to 80 weight-% of an inorganic initial material chemically bonded with 20 to 70 weight-% of an organic initial material, wherein the inorganic initial material is selected from the group consisting of a biocompatable silicate glass, silicate glass ceramic or mixtures thereof having a composition by weight % of ______________________________________ SiO.sub.2 = 34-60 Al.sub.2 O.sub.3 = 21-36 MgO = 8-17 R.sub.2 O = 5-12 F.sup.- = 1-7 ______________________________________ wherein R 2 O represents the sum of 0-8 weight-% Na 2 O and 0-6 weight-% K 2 O, a bioactive phosphosilicate glass, a phosphosilicate glass ceramic (A) or mixtures thereof having a composition by weight % of ______________________________________ SiO.sub.2 = 19-52 Al.sub.2 O.sub.3 = 12-23 MgO 5-15 R.sub.2 O = 3-10 CaO = 9-30 P.sub.2 O.sub.5 4-24 F.sup.- 0.5-7 ______________________________________ wherein R 2 O represents the sum of 0-8 weight-% Na 2 O and 0-8 weight-% K 2 O, a bioactive phosphosilicate glass, a phosphosilicate glass ceramic (B) or mixtures thereof having a composition by weight % of ______________________________________ SiO.sub.2 = 18-63 MgO = 10-35 K.sub.2 O = 3-10 F.sup.- = 4-9 CaO = 1-30 P.sub.2 O.sub.5 = 1-30 ______________________________________ a bioactive phosphate glass, a phosphate glass ceramic or mixtures thereof having a composition by weight % of ______________________________________ P.sub.2 O.sub.5 = 43-58 Al.sub.2 O.sub.3 = 3-21 CaO = 8-26 R.sub.2 O = 10-25 ______________________________________ wherein R 2 O can contain up to 25 weight-% Na 2 O and up to 18 weight-% K 2 O, a sintered ceramic comprising tricalcium phosphate apatite or mixtures thereof and mixtures thereof, and the organic initial material comprises a biocompatible, monomer-free, epoxidized polymeric hydrocarbon composed only of the elements C, H, O having an average molecular weight Mn of 2,000 to 6,000 and an epoxy equivalence EEW of 50 to 500 g, wherein the inorganic initial material has been pretreated with phosphoric acid to facilitate said chemical bonding between the organic and inorganic initial materials.
Claim 3
Dependent Claim 54 words
Inorganic-organic compound substances according to claim 1, wherein the inorganic initial material comprises said silicate glass, silicate glass ceramic or mixtures thereof and additionally contains up to 10 weight-% of an additive selected from the group consisting of FeO, Fe 2 O 3 , CaO, P 2 O 5 , BaO and mixtures thereof.
Claim 4
Dependent Claim 53 words
Inorganic-organic compound substances according to claim 1, wherein the inorganic initial material comprises said bioactive phosphosilicate glass, phosphate silicate glass ceramic (A) or mixtures thereof and additionally contains up to 10 weight-% of an additive selected from the group consisting of FeO, Fe 2 O 3 , BaO, TiO 2 and mixtures thereof.
Claim 5
Dependent Claim 58 words
Inorganic-organic compound substances according to claim 1, wherein the inorganic initial material comprises said bioactive phosphate silicate glass, phosphosilicate glass ceramic (B) or mixtures thereof and additionally contains up to 6 weight-% of an additive selected from the group consisting of Al 2 O 3 , TiO 2 , ZrO 2 , Na 2 O and mixtures thereof.
Claim 6
Dependent Claim 63 words
Inorganic-organic compound substances according to claim 1, wherein the inorganic initial material comprises said bioactive phosphate glass, phosphate glass ceramic or mixtures thereof and additionally contains up to 10 weight-% of an additive selected from the group consisting of TiO 2 , B 2 O 3 , F - , SiO 2 , FeO, Fe 2 O 3 , MgO and mixture thereof.
Claim 7
Dependent Claim 33 words
Inorganic-organic compound substances according to claim 1, wherein said inorganic initial material contains main crystal phases selected from the group consisting of mica, apatite, apatite and SiO 2 -isotype crystals and mixtures thereof.
Claim 8
Dependent Claim 29 words
Inorganic-organic compound substances according to claim 1, wherein the organic initial material contains additives selected from the group consisting of coloring components, antibiotics, hydrophilicity increasing components and mixtures thereof.
Claim 9
Dependent Claim 16 words
Inorganic-organic compound substances according to claim 7, wherein said hydrophilicity-increasing components comprise poly(vinyl alcohol-acrylic acid) copolymers.
Claim 10
Independent Claim 370 words
A method of producing inorganic-organic compound substances useful for biomedical purposes, comprising treating an inorganic initial material with 30 to 50% H 3 PO 4 for 1 to 24 hours at 25° to 130° C., said inorganic initial material being selected from the group consisting of a biocompatible silicate glass, a silicate glass ceramic or mixtures thereof having a composition by weight % of ______________________________________ SiO.sub.2 = 34-60 Al.sub.2 O.sub.3 = 21-36 MgO = 8-17 R.sub.2 O = 5-12 F.sup.- = 1-7 ______________________________________ wherein R 2 O represents the sum of 0-8 weight-% Na 2 O and 0-6 weight-% K 2 O, a bioactive phosphosilicate glass, a phosphosilicate glass ceramic (A) or mixtures thereof having a composition by weight % of ______________________________________ SiO.sub.2 = 19-52 Al.sub.2 O.sub.3 = 12-23 MgO 5-15 R.sub.2 O = 3-10 CaO = 9-30 P.sub.2 O.sub.5 4-24 F.sup.- 0.5-7 ______________________________________ wherein R 2 O represents the sum of 0-8 weight-% Na 2 O and 0-8 weight-% K 2 O, a bioactive phosphosilicate glass, a phosphosilicate glass ceramic (B) or mixtures thereof having a composition by weight % of ______________________________________ SiO.sub.2 = 18-63 MgO = 10-35 K.sub.2 O = 3-10 F.sup.- = 4-9 CaO = 1-30 P.sub.2 O.sub.5 = 1-30 ______________________________________ a bioactive phosphate glass, a phosphate glass ceramic or mixtures thereof having a composition by weight % of ______________________________________ P.sub.2 O.sub.5 = 43-58 Al.sub.2 O.sub.3 = 3-21 CaO = 8-26 R.sub.2 O = 10-25 ______________________________________ wherein R 2 O can contain up to 25 weight-% Na 2 O and up to 18 weight-% K 2 O, a sintered ceramic comprising tricalcium phosphate, apatite and mixtures thereof; mixing 30 to 80 weight-% of said treated inorganic initial material with 20 to 70 weight-% of an organic initial material comprising a biocompatible, monomer-free, epoxidized polymeric hydrocarbon composed only of the elements C, H, O having an average molecular weight Mn of 2,000 to 6,000 and an epoxy equivalence EEW of 50 to 500 g, at a temperature of 45° C. or less, to form a final reacted and chemically bonded inorganic-organic material resembling bone or cartilage suitable for endoprostheses, bone defect substitutions and body cartilage replacements, whereby said treatment with H 3 PO 4 facilitates said chemical bonding.
Claim 11
Independent Claim 370 words
A method of producing inorganic-organic compound substances useful for biomedical purposes, comprising treating an inorganic initial material with 30 to 50% H 3 PO 4 for 1 to 24 hours at 25° to 130° C., said inorganic initial material being selected from the group consisting of a biocompatible silicate glass, a silicate glass ceramic or mixtures thereof having a composition by weight % of ______________________________________ SiO.sub.2 = 34-60 Al.sub.2 O.sub.3 = 21-36 MgO = 8-17 R.sub.2 O = 5-12 F.sup.- = 1-7 ______________________________________ wherein R 2 O represents the sum of 0-8 weight-% Na 2 O and 0-6 weight-% K 2 O, a bioactive phosphosilicate glass, a phosphosilicate glass ceramic (A) or mixtures thereof having a composition by weight % of ______________________________________ SiO.sub.2 = 19-52 Al.sub.2 O.sub.3 = 12-23 MgO 5-15 R.sub.2 O = 3-10 CaO = 9-30 P.sub.2 O.sub.5 4-24 F.sup.- 0.5-7 ______________________________________ wherein R 2 O represents the sum of 0-8 weight-% Na 2 O and 0-8 weight-% K 2 O, a bioactive phosphosilicate glass, a phosphosilicate glass ceramic (B) or mixtures thereof having a composition by weight % of ______________________________________ SiO.sub.2 = 18-63 MgO = 10-35 K.sub.2 O = 3-10 F.sup.- = 4-9 CaO = 1-30 P.sub.2 O.sub.5 = 1-30 ______________________________________ a bioactive phosphate glass, a phosphate glass ceramic or mixtures thereof having a composition by weight % of ______________________________________ P.sub.2 O.sub.5 = 43-58 Al.sub.2 O.sub.3 = 3-21 CaO = 8-26 R.sub.2 O = 10-25 ______________________________________ wherein R 2 O can contain up to 25 weight-% Na 2 O and up to 18 weight-% K 2 O, a sintered ceramic comprising tricalcium phosphate, apatite and mixtures thereof; mixing 30 to 80 weight-% of said treated inorganic initial material with 20 to 70 weight-% of an organic initial material comprising a biocompatible, monomer-free, epoxidized polymeric hydrocarbon composed only of the elements C, H, O having an average molecular weight Mn of 2,000 to 6,000 and an epoxy equivalence EEW of 50 to 500 g, at a temperature of 45° C. or less, to form a final reacted and chemically bonded inorganic-organic material resembling bone or cartilage suitable for endoprostheses, bone defect substitutions and body cartilage replacements, whereby said treatment with H 3 PO 4 facilitates said chemical bonding.
Claim 12
Independent Claim 270 words
A method for producing inorganic-organic compound substances useful for biomedical purposes, comprising treating an inorganic initial material with 30 to 50% H 3 PO 4 for 1 to 24 hours at 25° to 130° C., said inorganic initial material being selected from the group consisting of a biocompatible silicate glass, a silicate glass ceramic or mixtures thereof having a composition by weight % of ______________________________________ SiO.sub.2 = 34-60 Al.sub.2 O.sub.3 = 21-36 MgO = 8-17 R.sub.2 O = 5-12 F.sup.- = 1-7 ______________________________________ wherein R 2 O represents the sum of 0-8 weight-% Na 2 O and 0-6 weight-% K 2 O, a bioactive phosphosilicate glass, a phosphosilicate glass ceramic (A) or mixtures thereof having a composition by weight % of ______________________________________ SiO.sub.2 = 19-52 Al.sub.2 O.sub.3 = 12-23 MgO 5-15 R.sub.2 O = 3-10 CaO = 9-30 P.sub.2 O.sub.5 4-24 F.sup.- 0.5-7 ______________________________________ wherein R 2 O represents the sum of 0-8 weight-% Na 2 O and 0-8 weight-% K 2 O, a bioactive phosphosilicate glass, a phosphosilicate glass ceramic (B) or mixtures thereof having a composition by weight % of ______________________________________ SiO.sub.2 = 18-63 MgO = 10-35 K.sub.2 O = 3-10 F.sup.- = 4-9 CaO = 1-30 P.sub.2 O.sub.5 = 1-30 ______________________________________ a bioactive phosphate glass, a phosphate glass ceramic or mixtures thereof having a composition by weight % of ______________________________________ P.sub.2 O.sub.5 = 43-58 Al.sub.2 O.sub.3 = 3-21 CaO = 8-26 R.sub.2 O = 10-25 ______________________________________ wherein R 2 O can contain up to 25 weight-% Na 2 O and up to 18 weight-% K 2 O, a sintered ceramic comprising tricalcium phosphate, apatite and mixtures thereof;
Claim 13
Independent Claim 270 words
A method for producing inorganic-organic compound substances useful for biomedical purposes, comprising treating an inorganic initial material with 30 to 50% H 3 PO 4 for 1 to 24 hours at 25° to 130° C., said inorganic initial material being selected from the group consisting of a biocompatible silicate glass, a silicate glass ceramic or mixtures thereof having a composition by weight % of ______________________________________ SiO.sub.2 = 34-60 Al.sub.2 O.sub.3 = 21-36 MgO = 8-17 R.sub.2 O = 5-12 F.sup.- = 1-7 ______________________________________ wherein R 2 O represents the sum of 0-8 weight-% Na 2 O and 0-6 weight-% K 2 O, a bioactive phosphosilicate glass, a phosphosilicate glass ceramic (A) or mixtures thereof having a composition by weight % of ______________________________________ SiO.sub.2 = 19-52 Al.sub.2 O.sub.3 = 12-23 MgO 5-15 R.sub.2 O = 3-10 CaO = 9-30 P.sub.2 O.sub.5 4-24 F.sup.- 0.5-7 ______________________________________ wherein R 2 O represents the sum of 0-8 weight-% Na 2 O and 0-8 weight-% K 2 O, a bioactive phosphosilicate glass, a phosphosilicate glass ceramic (B) or mixtures thereof having a composition by weight % of ______________________________________ SiO.sub.2 = 18-63 MgO = 10-35 K.sub.2 O = 3-10 F.sup.- = 4-9 CaO = 1-30 P.sub.2 O.sub.5 = 1-30 ______________________________________ a bioactive phosphate glass, a phosphate glass ceramic or mixtures thereof having a composition by weight % of ______________________________________ P.sub.2 O.sub.5 = 43-58 Al.sub.2 O.sub.3 = 3-21 CaO = 8-26 R.sub.2 O = 10-25 ______________________________________ wherein R 2 O can contain up to 25 weight-% Na 2 O and up to 18 weight-% K 2 O, a sintered ceramic comprising tricalcium phosphate, apatite and mixtures thereof;
Claim 14
Dependent Claim 105 words
mixing 30 to 80 weight-% of said inorganic initial material with 20 to 70 weight-% of an organic initial material comprising a biocompatible, monomer-free, epoxidized polymeric hydrocarbon composed only of the elements C, H, O having an average molecular weight Mn of 2,000 to 6,000 and an epoxy equivalence EEW of 50 to 500 g, to form a reacted and chemically bonded inorganic-organic material, whereby said treatment with H 3 PO 4 facilitates said chemical bonding; and hardening said reacted inorganic-organic material to a particular shape at 25° to 100° C. to attain an implant material having long-term stability and various bioactive or biocompatible characteristics.
Claim 15
Dependent Claim 105 words
mixing 30 to 80 weight-% of said inorganic initial material with 20 to 70 weight-% of an organic initial material comprising a biocompatible, monomer-free, epoxidized polymeric hydrocarbon composed only of the elements C, H, O having an average molecular weight Mn of 2,000 to 6,000 and an epoxy equivalence EEW of 50 to 500 g, to form a reacted and chemically bonded inorganic-organic material, whereby said treatment with H 3 PO 4 facilitates said chemical bonding; and hardening said reacted inorganic-organic material to a particular shape at 25° to 100° C. to attain an implant material having long-term stability and various bioactive or biocompatible characteristics.
Claim 16
Independent Claim 364 words
A method of producing inorganic-organic compound substances useful for biomedical purposes, comprising treating an inorganic initial material with 50% H 3 PO 4 for 12 hours at 110° C., said inorganic initial material being selected from the group consisting of a biocompatible silicate glass, a silicate glass ceramic or mixtures thereof having a composition by weight % of ______________________________________ SiO.sub.2 = 34-60 Al.sub.2 O.sub.3 = 21-36 MgO = 8-17 R.sub.2 O = 5-12 F.sup.- = 1-7 ______________________________________ wherein R 2 O represents the sum of 0-8 weight-% Na 2 O and 0-6 weight-% K 2 O, a bioactive phosphosilicate glass, a phosphosilicate glass ceramic (A) or mixtures thereof having a composition by weight % of ______________________________________ SiO.sub.2 = 19-52 Al.sub.2 O.sub.3 = 12-23 MgO 5-15 R.sub.2 O = 3-10 CaO = 9-30 P.sub.2 O.sub.5 4-24 F.sup.- 0.5-7 ______________________________________ wherein R 2 O represents the sum of 0-8 weight-% Na 2 O and 0-8 weight-% K 2 O, a bioactive phosphosilicate glass, a phosphosilicate glass ceramic (B) or mixtures thereof having a composition by weight % of ______________________________________ SiO.sub.2 = 18-63 MgO = 10-35 K.sub.2 O = 3-10 F.sup.- = 4-9 CaO = 1-30 P.sub.2 O.sub.5 = 1-30 ______________________________________ a bioactive phosphate glass, a phosphate glass ceramic or mixtures thereof having a composition by weight % of ______________________________________ P.sub.2 O.sub.5 = 43-58 Al.sub.2 O.sub.3 = 3-21 CaO = 8-26 R.sub.2 O = 10-25 ______________________________________ wherein R 2 O can contain up to 25 weight-% Na 2 O and up to 18 weight-% K 2 O, a sintered ceramic comprising tricalcium phosphate, apatite and mixtures thereof; mixing 30 to 80 weight-% of said inorganic initial material with 20 to 70 weight-% of an organic initial material comprising a biocompatible, monomer-free, epoxidized polymeric hydrocarbon composed only of the elements C, H, O having an average molecular weight Mn of 2,000 to 6,000 and an epoxy equivalence EEW of 50 to 500 g, to form a reacted and chemically bonded inorganic-organic material hardening to within 80% of final hardness within 20 minutes after mixing suitable for use as a tooth filling material and tooth structure material, whereby said treatment with H 3 PO 4 facilitates said chemical bonding.
Claim 17
Independent Claim 364 words
A method of producing inorganic-organic compound substances useful for biomedical purposes, comprising treating an inorganic initial material with 50% H 3 PO 4 for 12 hours at 110° C., said inorganic initial material being selected from the group consisting of a biocompatible silicate glass, a silicate glass ceramic or mixtures thereof having a composition by weight % of ______________________________________ SiO.sub.2 = 34-60 Al.sub.2 O.sub.3 = 21-36 MgO = 8-17 R.sub.2 O = 5-12 F.sup.- = 1-7 ______________________________________ wherein R 2 O represents the sum of 0-8 weight-% Na 2 O and 0-6 weight-% K 2 O, a bioactive phosphosilicate glass, a phosphosilicate glass ceramic (A) or mixtures thereof having a composition by weight % of ______________________________________ SiO.sub.2 = 19-52 Al.sub.2 O.sub.3 = 12-23 MgO 5-15 R.sub.2 O = 3-10 CaO = 9-30 P.sub.2 O.sub.5 4-24 F.sup.- 0.5-7 ______________________________________ wherein R 2 O represents the sum of 0-8 weight-% Na 2 O and 0-8 weight-% K 2 O, a bioactive phosphosilicate glass, a phosphosilicate glass ceramic (B) or mixtures thereof having a composition by weight % of ______________________________________ SiO.sub.2 = 18-63 MgO = 10-35 K.sub.2 O = 3-10 F.sup.- = 4-9 CaO = 1-30 P.sub.2 O.sub.5 = 1-30 ______________________________________ a bioactive phosphate glass, a phosphate glass ceramic or mixtures thereof having a composition by weight % of ______________________________________ P.sub.2 O.sub.5 = 43-58 Al.sub.2 O.sub.3 = 3-21 CaO = 8-26 R.sub.2 O = 10-25 ______________________________________ wherein R 2 O can contain up to 25 weight-% Na 2 O and up to 18 weight-% K 2 O, a sintered ceramic comprising tricalcium phosphate, apatite and mixtures thereof; mixing 30 to 80 weight-% of said inorganic initial material with 20 to 70 weight-% of an organic initial material comprising a biocompatible, monomer-free, epoxidized polymeric hydrocarbon composed only of the elements C, H, O having an average molecular weight Mn of 2,000 to 6,000 and an epoxy equivalence EEW of 50 to 500 g, to form a reacted and chemically bonded inorganic-organic material hardening to within 80% of final hardness within 20 minutes after mixing suitable for use as a tooth filling material and tooth structure material, whereby said treatment with H 3 PO 4 facilitates said chemical bonding.

References Cited (Backward Citations)

US3400097A Cited
US3808170A Cited
US3973972A Cited
US4013610A Cited
US4131597A Cited
US4381918A Cited
US4215033A Cited
US4308014A Cited
US4548959A Cited
JPS56149389A Cited
US4560715A Cited
US4605570A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-03-15 1991-09-14 1992-03-15 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-03-15 1995-09-14 1996-03-15 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-03-15 1999-09-14 2000-03-15 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag